AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SVRA · NASDAQ · Biotechnology

Savara (SVRA)

Developing inhaled MOLBREEVI for autoimmune pulmonary alveolar proteinosis.

$5.50

Pre-market+0.04 (+0.73%)

At close$5.46(+2.06%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions190 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail	≈ 102.58%	210.77M shares
Insiders11 holders · as of Jul 24, 2026	1.48%	3.04M shares
Strategic holders1 holder · as of Feb 17, 2026	6.02%	12.36M shares
Adds to	110.08%

205.46M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 110.08%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Nea Management Company, LLCInstitution	11.91%	24.47M	13Fas of Mar 31, 2026
Venrock Healthcare Capital Partners III, L.P.Institution	10.16%	20.88M	13Gfiled Feb 17, 2026 ↗
Bain Capital Life Sciences Investors, LLCInstitution	8.57%	17.60M	13Fas of Mar 31, 2026
VR Adviser, LLCInstitution	6.69%	13.74M	13Fas of Mar 31, 2026
Deerfield Management Company, L.P. (Series C)Institution	6.60%	13.57M	13Fas of Mar 31, 2026
TCG Crossover Management, LLCInstitution	6.02%	12.36M	13Fas of Mar 31, 2026
TCG Crossover GP I, LLCStrategic	6.02%	12.36M	13Gfiled Feb 17, 2026 ↗
BlackRock, Inc.Institution	5.50%	11.29M	13Fas of Mar 31, 2026
Frazier Life Sciences Management, L.P.Institution	4.73%	9.72M	13Fas of Mar 31, 2026
Polar Capital Holdings PLCInstitution	4.64%	9.54M	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	3.79%	7.78M	13Fas of Mar 31, 2026
Nantahala Capital Management, LLCInstitution	3.57%	7.34M	13Fas of Mar 31, 2026
State Street CorpInstitution	3.26%	6.71M	13Fas of Mar 31, 2026
RTW Investments, LPInstitution	2.90%	5.95M	13Fas of Mar 31, 2026
Marshall Wace, LLPInstitution	2.20%	4.51M	13Fas of Mar 31, 2026
Woodline Partners LPInstitution	2.07%	4.25M	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	1.75%	3.59M	13Fas of Mar 31, 2026
Spruce Street Capital LPInstitution	1.65%	3.38M	13Fas of Mar 31, 2026
Emerald Advisers, LLCInstitution	1.64%	3.37M	13Fas of Mar 31, 2026
Rosalind Advisors, Inc.Institution	1.56%	3.20M	13Fas of Mar 31, 2026
Wellington Management Group LLPInstitution	1.32%	2.71M	13Fas of Mar 31, 2026
Vestal Point Capital, LPInstitution	1.27%	2.60M	13Fas of Mar 31, 2026
Affinity Asset Advisors, LLCInstitution	1.22%	2.51M	13Fas of Mar 31, 2026
Emerald Mutual Fund Advisers TrustInstitution	1.15%	2.37M	13Fas of Mar 31, 2026
Pictet Asset Management Holding SAInstitution	1.11%	2.28M	13Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

190 holders · 210.77M shares · 60 new positions · 124 increased · 37 reduced · 23 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Nea Management Company, LLC	24.47M	11.91%	0	May 15, 2026
Bain Capital Life Sciences Investors, LLC	17.60M	8.57%	0	May 15, 2026
VR Adviser, LLC	13.74M	6.69%	0	May 15, 2026
Deerfield Management Company, L.P. (Series C)	13.57M	6.60%	0	May 15, 2026
TCG Crossover Management, LLC	12.36M	6.02%	0	May 15, 2026
BlackRock, Inc.	11.29M	5.50%	+193.9K	May 13, 2026
Frazier Life Sciences Management, L.P.	9.72M	4.73%	−141.4K	May 15, 2026
Polar Capital Holdings PLC	9.54M	4.64%	+1.24M	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Growth Equity Opportunities 17, LLCincl. Carmen Chang, Anthony A. Florence, Jr. +10 more	12.00%	24.47M	13D	Nov 14, 2025 ↗
Bain Capital Life Sciences Fund II, L.P.incl. BCLS II Investco, LP, BCIP Life Sciences Associates, LP	9.99%	17.60M	13D	Mar 27, 2025 ↗
Venrock Healthcare Capital Partners III, L.P.	9.90%	20.88M	13G	Feb 17, 2026 ↗
Deerfield Mgmt, L.P.	6.74%	13.57M	13G	Nov 5, 2025 ↗
TCG Crossover GP I, LLC	6.10%	12.36M	13G	Feb 17, 2026 ↗
BlackRock, Inc.	5.70%	9.40M		Nov 8, 2024 ↗
Wellington Management Group LLPincl. Wellington Management Company LLP, Wellington Group Holdings LLP +1 more	5.24%	8.62M	13G	Nov 8, 2024 ↗
Patrick J. Heronincl. Albert Cha, Fhmls Xi, L.P. +14 more	5.00%	8.66M	13G	Nov 27, 2024 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jun 22, 2026	David L. Lowranceofficer: Chief Financial Officer	Sale	394,528	$5.68	536,032
Dec 19, 2025	David A. Ramsaydirector	Sale	20,000	$6.06	2,533,642

CongressHouse and Senate disclosures

Not reported.